Glover Eddie Wabern 4
4 · Adamis Pharmaceuticals Corp · Filed Feb 23, 2018
Insider Transaction Report
Form 4
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-21+35,000→ 35,000 totalExercise: $2.83Exp: 2028-02-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.